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SCIENCE FOR JUDGES VI INTRODUCTION 
 
Margaret A. Berger∗ 
 Once again, the Journal of Law and Policy is publishing 
papers relating to science and law that had their inception at a 
Science for Judges program for federal and state judges.1 The 
program, held at Brooklyn Law School on November 4 and 5, 
2005, was the sixth in a series of conferences funded by the 
Common Benefit Trust established in the Silicone Breast Implant 
Products Liability Litigation. These programs have been presented 
under the auspices of Brooklyn Law School’s Center for Health, 
Science and Public Policy in collaboration with the Federal 
Judicial Center, the National Center for State Courts, and the 
Committee on Science, Technology and Law of the National 
Academies of Science.  
November’s program conference was devoted to an exploration 
of evidence-based medicine. Understanding the methodology that 
evidence-based medicine brings to an evaluation of medical 
research seemed highly compatible with the objectives of these 
programs for judges because medical experts are among the most 
commonly used experts in court proceedings. They testify 
frequently in a wide variety of cases, such as toxic tort cases, 
                                                          
 ∗ Suzanne J. and Norman Miles Professor of Law, Brooklyn Law School. 
Professor Berger is the Director of the Science for Judges Program. 
 1 Papers from previous Science for Judges programs can be found in 12 J.L. 
& POL’Y 1, 1-53 (2003) (papers discussing the practice of epidemiology and the 
science produced by administrative agencies); 12 J.L. & POL’Y 485, 485-639 
(2004) (papers discussing toxicology and epidemiology); 13 J.L. & POL’Y 1, 1-
179 (2005) (papers discussing the integrity of scientific research and forensic 
evidence in criminal proceedings); 13 J.L. & POL’Y 499, 499-647 (2005) (papers 
discussing Agent Orange and human behavior research); 14 J.L. & POL’Y 1, 1-
209 (papers discussing risk assessment and data disclosure and protection). All 
papers are available in electronic form at http://brooklaw. 
edu/centers/scienceforjudges/papers.php. 
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medical malpractice actions, and insurance coverage disputes. The 
articles that follow have two major objectives: 1) to examine the 
role of evidence-based medicine in improving decision making by 
policy makers in a number of different arenas, and 2) to provide 
the reader with an understanding of the statistical concepts and 
technical vocabulary that researchers use when they employ the 
methodology of evidence-based medicine in reaching a conclusion 
about a disputed medical intervention, or in deciding that no 
conclusion is as yet warranted. 
The Fox-Greenfield article, Helping Public Officials Use 
Research Evaluating Health Care,2 provides background 
information by tracing the history of the evidence-based medicine 
movement and its progress in bringing information about outcomes 
to the attention of policy makers. It suggests that the judiciary too 
will benefit from knowing how to access systematic reviews and 
make use of their findings. Gibson’s article, When Good 
Information Truly Matters: Public Sector Decision Makers 
Acquiring and Using Research to Inform Their Decisions,3 follows 
up on the Fox-Greenfield discussion by examining a trend on the 
part of public officials to inform themselves rather than relying 
solely on information that others provide. This trend is leading 
public officials to seek, commission, and evaluate research needed 
to make decisions in the public interest. As an example, he then 
explores the Drug Effectiveness Review Project (DERP), a 
collaboration of fifteen states and two other organizations that 
commissions and uses systematic reviews of global research to 
inform drug purchasing decisions in their Medicaid, corrections, 
workers’ compensation, general health care, and employee benefits 
programs. In addition to explaining DERP’s process, he analyzes 
the criticisms that have been voiced about this initiative. 
Bero’s article, Evaluating Systematic Reviews and Meta-
Analyses,4 begins by explaining the strengths and importance of 
                                                          
 2 Daniel M. Fox & Lee Greenfield, Helping Public Officials Use Research 
Evaluating Healthcare, 14 J.L. & POL’Y 531 (2006). 
 3 Mark Gibson, When Good Information Truly Matters: Public Sector 
Decision Makers Acquiring and Using Research to Inform Their Decisions, 14 
J.L. & POL’Y  553 (2006). 
 4 Lisa A. Bero, Evaluating Systematic Reviews and Meta-Analyses, 14 J.L. 
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systematic reviews, and by providing an example of a meta-
analysis that showed that a widely-used treatment had no effect. 
She then turns to the complex question of how systematic reviews 
are evaluated for bias. After discussing how to set up protocols 
before a study begins, to ensure that researchers cannot adjust their 
analysis midstream if they are disappointed by the conclusions that 
are emerging, she turns to defining various types of bias and how 
bias can be detected and eliminated. Judges and lawyers should 
find her exposition extremely useful in evaluating studies on which 
expert witnesses seek to rely. Her discussion also points out, 
however, how difficult it may be to arrive at a definitive answer. 
Although evidence-based medicine seeks to arrive at statistically 
significant research results that are true, Bero’s paper 
acknowledges the many different obstacles that may have to be 
overcome. 
The Lerner-Robertson article, When There Are No Randomized 
Controlled Trials: A Case History of a Controversial Procedure 
for Metastatic Breast Cancer,5 is a fascinating and troubling 
account of the use of bone marrow transplants to treat advanced 
cases of breast cancer even though the technique’s effectiveness 
had not been studied. Lerner and Robertson paint a vivid picture of 
the various forces that combined to demand the transplant 
procedure despite the lack of scientific information, the huge cost, 
and deaths that resulted from the treatment. This cautionary tale of 
oncologists, politicians, scientific fraud, and advocates for women 
provides a remarkable glimpse of the various players, including the 
courts which became involved because of suits by women denied 
insurance coverage. The article also explains how ultimately the 
ineffectiveness of the transplants was shown despite the absence of 
randomized controlled trials by using an approach that combined 
data from uncontrolled trials. Certainly, the value of evidence-
based approaches is validated by this experience. 
But there is a limit to how useful evidence-based medicine can 
be in judicial proceedings. Much will depend on the question 
                                                          
& POL’Y 571 (2006). 
 5 Jeffrey C. Lerner & Diane C. Robertson, When There Are No Randomized 
Controlled Trials: A Case History of a Controversial Procedure for Metastatic 
Breast Cancer, 14 J.L. & POL’Y  597 (2006). 
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before the court. Systematic reviews of randomized controlled 
studies are the gold standard in determining whether an 
intervention is efficacious and may therefore be extremely useful 
in malpractice cases and insurance disputes. However, 
observational studies are much more likely to play a role in 
assessing causation in toxic tort cases. 
It is, however, not only the issue that will determine the 
usefulness of an evidence-based medicine approach. This approach 
evaluates the strength of existing evidence. Often, of course, in 
legal proceedings there will be no studies that satisfy the standards 
of evidence-based medicine. What does the judge do then? How 
should gaps in knowledge be treated? Can inferences be drawn 
against a party that possesses information which it failed to supply, 
such as negative trials, or that failed to conduct additional 
research? Can one combine other kinds of evidence with studies 
that are insufficient in themselves to prove the issue in 
controversy? How does one synthesize these different types of 
evidence? What is the applicable standard of proof that scientific 
evidence must meetis it the rigorous standard that the 
practitioners of science-based medicine use when they decide a 
conclusion is warranted, or is it the lower preponderance of 
evidence standard that applies in civil litigation? What role do 
conflicts of interest or bias play? These are all fascinating 
questions that are beyond the scope of this Science for Judges 
program. Some have been discussed at previous programs and at 
the Science for Judges VII program which was held in March 2006. 
Papers from that conference will be published in a forthcoming 
issue of the Journal of Law and Policy. The oral presentations 
made at the March program are available now at the Science for 
Judges website.6 
The articles that follow provide rich food for thought for all 
those interested in the interaction of science and law and the role of 
public policy in decision making. The Science for Judges program 
and the Journal of Law and Policy wish to thank Dan Fox for 
                                                          
6 Brooklyn Law School, Center for Health, Science and Public Policy, 
Science for Judges, http://www.brooklaw.edu/centers/scienceforjudges/ 
events.php. 
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assembling the authors of these important and timely pieces. 
 
